Found: 5
Select item for more details and to access through your institution.
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
- Published in:
- Cardio-Oncology, 2024, v. 10, p. 1, doi. 10.1186/s40959-023-00191-0
- By:
- Publication type:
- Article
Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
- Published in:
- Cardio-Oncology, 2024, v. 10, p. 1, doi. 10.1186/s40959-023-00191-0
- By:
- Publication type:
- Article
Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.
- Published in:
- Cardio-Oncology, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40959-023-00191-0
- By:
- Publication type:
- Article
Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice